Impact of court delays on Ribociclib access for breast cancer patients
The accessibility of breast cancer treatment in India is facing scrutiny following a legal petition for affordable access to the essential drug Ribociclib. The case has faced significant setbacks, remaining unheard despite being scheduled for a final hearing 57 times at the Kerala High Court since January 2023. Sadly, the individual who filed the petition passed away during the initial phases of the legal process.
by shortkt.com✓